Insulin Resistance presentations about Insulin Resistance EB with interest for Insulin Resistance Validating Insulin Resistance content Free registration form / enregistrement gratuit
1
2
   - December 1, 2008
Welcome to the #1 online source of information for Diabetes Specialists! An international online community of more than 10,000 Diabetes Specialists.

CME on Diabetes is a website built to transmit top-level CME conferences given by international experts in endocrinology, insulin resistance, prediabetes, metabolic syndrome and type 2 diabetes. More than 2.6 million slides have been viewed since the website launch. Thank you for your continued support and commitment!
 Presentation

"Is self-monitoring of blood glucose (SMBG) worthwhile in type 2 diabetes? Findings from the Fremantle Diabetes Study"

Prof. Timothy Davis (biography)
English - 2007-05-31 - 37 minutes
(32 slides)

Summary :
Although self-monitoring of blood glucose (SMBG) is unanimously recommended for type 2 diabetic patients treated with insulin, there is no international consensus on whether SMBG is required in those on diet or oral antihyperglycaemic treatment (1).

Here Prof. Davis presents recently published data from the prospective, observational Fremantle Diabetes Study (FDS). These analyses address the questions of whether SMBG is appropriate for all type 2 diabetics, and whether it reduces outcomes in these patients (2,3). Also of interest is the epidemiological European ROSSO study in type 2 diabetic patients, which investigated the relationship of SMBG with diabetes-related morbidity and all-cause mortality (4). Prof. Davis discusses the findings from these studies, and why there is a need for careful assessment of the value of SMBG in non-insulin-treated type 2 diabetic patients.

Copyright © 2007 E-MedHosting.com Inc.

Learning objectives :
After viewing this presentation the participant will be able to discuss:

- The value of self-monitoring of blood glucose in type 2 diabetes

Bibliographic references :
1. Burgers JS, Bailey JV, Klazinga NS, Van Der Bij AK, Grol R, Feder G; AGREE COLLABORATION.Comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries Diabetes Care 25:1933-1939, 2002.

2. Wendy A. Davis, PHD, David G. Bruce, MD and Timothy M.E. Davis, DPHILIs Self-Monitoring of Blood Glucose Appropriate for All Type 2 Diabetic Patients? Diabetes Care 29:1764-1770, 2006.

3. W. A. Davis, D. G. Bruce1 and T. M. E. Davis. Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes Study Diabetologia 2007;50:510-515.

4. S. Martin, B. Schneider, L. Heinemann, V. Lodwig, H.-J. Kurth, H. Kolb, W. A. Scherbaum and for the ROSSO Study Group.Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study Diabetologia 2006;49:271-278.

   


  Login
  Username :
  Password :
   
  Lost your password?


  Search our website
  Would you like to know more about insulin resistance? Are you looking for information pertaining to Type 2 Diabetes? You can find what you are looking for in over 2000 references available on CMEonDiabetes.
 

  Social
  Let others know about this presentation.

 Del.icio.us
 Digg!



ezCME: HIV - Insulin Resistance - C-Reactive Protein (CRP) - ADHD - Sleep Disorder - Prostate Health - Hemophilia - Transplantation

Copyright © 2002-2008 E-MedHosting.com. All rights reserved.  Disclaimer  |  Sponsor Disclaimer
Powered by Multiwebcast - webcast services


USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.
insulin resistanceC-Reactive Protein (CRP)CRP, C-Reactive ProteinADHD ADDdiabetes insulin